Recurrence-free survival and prognosis after adjuvant therapy with radioactive iodine-131 in patients with differentiated thyroid carcinoma

This study aimed to assess recurrence-free survival (RFS) rates and recurrence-related factors of patients who received adjuvant therapy (AT) with radioactive iodine (RAI) for differentiated thyroid cancer (DTC) following thyroidectomy. We evaluated 284 patients who underwent AT between January 2011...

Descripción completa

Detalles Bibliográficos
Autores principales: Iizuka, Yusuke, Katagiri, Tomohiro, Ogura, Kengo, Inoue, Minoru, Nakashima, Ryota, Nakamura, Kiyonao, Mizowaki, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319734/
https://www.ncbi.nlm.nih.gov/pubmed/37402838
http://dx.doi.org/10.1038/s41598-023-37899-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319734/
https://www.ncbi.nlm.nih.gov/pubmed/37402838
http://dx.doi.org/10.1038/s41598-023-37899-z

Ejemplares similares